Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Ultrasound's initial medical applications were limited to thermal ablation and diagnostics.
• Nanoparticle-based drug delivery represents a significant advancement in cancer therapy.
• Conventional chemotherapy often causes severe side effects due to systemic drug exposure.

Purpose of the Study:

• To review the application of ultrasound in enhancing nanoparticle drug delivery for cancer treatment.
• To discuss the physics of ultrasound and its role in controlled drug release.
• To highlight the potential of this non-invasive modality in reducing chemotherapy side effects.

Main Methods:

• Review of preclinical research on ultrasound-mediated drug delivery.
• Discussion of nanoparticle drug carriers, with a focus on liposomes.
• Presentation and analysis of in vitro and in vivo study examples.

Main Results:

• Ultrasound enables spatial and temporal control over drug release from nanoparticles.
• This targeted approach reduces the interaction of anti-neoplastic agents with healthy tissues.
• Nanoparticle-drug conjugates show promise for localized cancer treatment.

Conclusions:

• Ultrasound-triggered nanoparticle drug delivery is a promising non-invasive cancer therapy strategy.
• This method offers improved therapeutic efficacy and reduced systemic toxicity compared to conventional chemotherapy.
• Further preclinical studies support the potential of ultrasound and nanoparticles in oncology.